Aclaris Therapeutics, Inc. (ACRS) stock
ACRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30138% above fair value
$3.50+0.12 (+3.55%)
Close on Nov 18, 2026Market cap $515.20MP/E –Yield –
Aclaris Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Aclaris Therapeutics's market cap was $606.84M on Nov 11, 2026, against $306.61M a year earlier. Over the last 5 years it ranged from $61.95M to $1.13B, with a median of $484.77M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $606.84M | +86.1% |
| 2025 | Dec 31, 2025 | $326.11M | +84.1% |
| 2024 | Dec 31, 2024 | $177.12M | +138.2% |
| 2023 | Dec 29, 2023 | $74.36M | -92.9% |
| 2022 | Dec 30, 2022 | $1.05B | +18.0% |
| 2021 | Dec 31, 2021 | $890.24M | +220.6% |
| 2020 | Dec 31, 2020 | $277.67M | +255.0% |
| 2019 | Dec 31, 2019 | $78.21M | -65.9% |
| 2018 | Dec 31, 2018 | $229.02M | -69.9% |
| 2017 | Dec 29, 2017 | $760.38M | +30.8% |
| 2016 | Dec 30, 2016 | $581.45M | +690.5% |
| 2015 | Dec 31, 2015 | $73.56M | – |
See a number that looks wrong?